What I am working with: dulaglutide · 5 mg/mL.
This is a procedural question rather than a theoretical one, and I would like the procedure rather than the theory.
What I have done so far is read the label documentation where it exists and the two pharmacopoeial monographs that are publicly available, which cover the licensed presentation and say nothing about a research one.
What would you do, and what would you check afterwards?
Nobody has published a cycle count, and at 5 mg/mL the concentration tells you what a wrong guess costs: a 0.1 mL aliquot holds 0.5 mg and every microlitre is 5 µg. Damage from freezing is not gradual attrition — it is concentrated at the phase transitions, where ice excludes solute and the unfrozen fraction climbs well above 5 mg/mL for as long as the transition lasts. Two slow cycles can therefore do more than four fast ones, which is why a cycle count is the wrong unit in the first place. The way to make the number one is to make it one: split at reconstitution into single-draw aliquots, label each with 5 mg/mL and the date, and never thaw a container you will refreeze.
The honest answer is that people worry about the freezer temperature and should worry about the number of cycles.
Buffer salts crystallise at different points during freezing. Sodium phosphate is the classic example: the dibasic form crystallises first and the pH of the residual liquid falls by several units. That pH excursion is the real damage in many cases.
It helps to be literal here: a dry lyophilised powder is much less affected by a temperature cycle because there is no liquid phase for anything to concentrate into. Condensation on a cold vial opened warm is the real risk there.
Aliquoting to eliminate repeated cycles is standard laboratory practice for exactly this reason.
Nothing here is medical advice, and research-use compounds are not approved for human use.
Count cycles, not degrees. The cycle is the damaging event.
edited 2 Aug 2025 by esben_lykke — updated for the 2026 guidance change
HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.
Submit a sampleFounded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.
Visit GL BiochemThis is one of the few handling questions with a genuinely quantitative literature behind it.
During freezing, solutes are excluded from the ice lattice and concentrate into the residual liquid. Local concentrations can rise many-fold, which promotes aggregation independently of temperature.
Count cycles rather than worrying about degrees. Minus twenty and minus eighty differ far less than one cycle and five do.
Condensation onto cold lyophilised material on opening is a recognised handling error and is the basis for the equilibrate-before-opening rule.
The number of tolerable cycles is sequence- and formulation-dependent and no general number is honest.
Let a frozen vial reach room temperature before opening, or you condense water into it.
Answering this needs to know whether the material is dry or in solution, since a dry powder is largely indifferent to a temperature cycle.
Thaw slowly at room temperature or in the refrigerator rather than in warm water. Rapid warming creates local thermal and concentration gradients that promote aggregation.
Never refreeze a thawed aliquot. The whole point of aliquoting is that the aliquot is single-use, and refreezing it discards the benefit.
The caveat is that aggregation is invisible in a clear solution below the threshold where it becomes visible.
Thaw slowly and never refreeze an aliquot.
Answer first: each freeze-thaw cycle costs something through aggregation and pH shift, so the mitigation is aliquoting rather than choosing a better freezer.
The mitigation is aliquoting. Divide the reconstituted solution into single-use volumes before the first freeze, and each aliquot then experiences exactly one cycle.
Selective crystallisation of sodium phosphate buffer components producing large pH shifts on freezing is a classical result in the lyophilisation literature.
Aliquoting itself is a handling step and introduces its own contamination opportunity.
Aliquot before the first freeze. That is the whole answer.
The short version: aliquot before freezing, thaw slowly, never refreeze a thawed aliquot, and count your cycles.
Let a frozen vial reach room temperature before opening it. Opening a cold vial in humid air condenses water into the cake, which raises residual moisture and undoes what lyophilisation achieved.
Cryoconcentration of solutes at the ice front is a well-documented mechanism in freeze-thaw damage to proteins and peptides.
The caveat is that "within specification" and "unchanged" are different claims. A vial can lose a few per cent of content and still be usable for its purpose while no longer matching its certificate.
Dry powder tolerates cycles far better than solution does.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.